Ed Arce

Stock Analyst at HC Wainwright & Co.

(3.23)
# 1,444
Out of 4,459 analysts
323
Total ratings
38.61%
Success rate
3.45%
Average return

35 Stocks

Mirum Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $58$66
Current: $29.25
Upside: +125.64%
Sagimet Biosciences
Jun 14, 2024
Reiterates: Buy
Price Target: $32
Current: $3.95
Upside: +710.13%
Assembly Biosciences
Jun 13, 2024
Reiterates: Neutral
Price Target: n/a
Current: $14.88
Upside: -
Genfit
Jun 11, 2024
Maintains: Buy
Price Target: $11$13
Current: $4.15
Upside: +213.25%
89bio
Jun 11, 2024
Reiterates: Buy
Price Target: $29
Current: $8.40
Upside: +245.24%
Akero Therapeutics
Jun 11, 2024
Reiterates: Buy
Price Target: $50
Current: $22.16
Upside: +125.63%
Arbutus Biopharma
Jun 7, 2024
Reiterates: Buy
Price Target: $5
Current: $3.01
Upside: +66.11%
Pliant Therapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $36
Current: $10.71
Upside: +236.13%
Iterum Therapeutics
May 31, 2024
Reiterates: Buy
Price Target: $6
Current: $1.12
Upside: +435.71%
Unicycive Therapeutics
May 29, 2024
Reiterates: Buy
Price Target: $4.5
Current: $0.65
Upside: +596.81%
DURECT
May 22, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Acurx Pharmaceuticals
May 16, 2024
Reiterates: Buy
Price Target: $12
Current: $2.25
Upside: +433.33%
Talphera
May 15, 2024
Reiterates: Buy
Price Target: $6
Current: $0.78
Upside: +668.15%
Terns Pharmaceuticals
May 14, 2024
Reiterates: Neutral
Price Target: $5.5
Current: $7.37
Upside: -25.37%
Madrigal Pharmaceuticals
May 8, 2024
Maintains: Buy
Price Target: $425$390
Current: $276.01
Upside: +41.30%
Travere Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $19
Current: $7.10
Upside: +167.61%
Enanta Pharmaceuticals
May 7, 2024
Maintains: Buy
Price Target: $28$27
Current: $11.83
Upside: +128.23%
Galectin Therapeutics
Apr 9, 2024
Reiterates: Buy
Price Target: $11
Current: $2.33
Upside: +372.10%
Cidara Therapeutics
Apr 8, 2024
Maintains: Buy
Price Target: $120
Current: $12.10
Upside: +891.74%
Inventiva
Apr 1, 2024
Reiterates: Buy
Price Target: $22
Current: $2.62
Upside: +739.53%
Akebia Therapeutics
Mar 28, 2024
Maintains: Buy
Price Target: $5$6
Current: $1.01
Upside: +494.06%
ZyVersa Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $240
Current: $5.05
Upside: +4,652.48%
Synlogic
Mar 20, 2024
Upgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Arcturus Therapeutics Holdings
Mar 8, 2024
Reiterates: Buy
Price Target: $60
Current: $25.96
Upside: +131.12%
Aurinia Pharmaceuticals
Mar 1, 2024
Reiterates: Buy
Price Target: $13
Current: $5.42
Upside: +139.85%
Vera Therapeutics
Dec 27, 2023
Reiterates: Buy
Price Target: $25
Current: $35.53
Upside: -29.64%
Ardelyx
Nov 1, 2023
Maintains: Buy
Price Target: $9$11
Current: $5.95
Upside: +84.87%
Ultragenyx Pharmaceutical
Aug 1, 2023
Reiterates: Buy
Price Target: $82
Current: $37.42
Upside: +119.13%
Galmed Pharmaceuticals
May 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Avenue Therapeutics
May 12, 2020
Maintains: Buy
Price Target: $13,500$14,625
Current: $3.63
Upside: +402,792.56%
Summit Therapeutics
Mar 19, 2020
Initiates: Buy
Price Target: n/a
Current: $7.94
Upside: -
Trevena
Nov 5, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -
Viking Therapeutics
Nov 10, 2017
Assumes: Buy
Price Target: n/a
Current: $50.64
Upside: -
Collegium Pharmaceutical
Sep 11, 2017
Initiates: Buy
Price Target: n/a
Current: $32.15
Upside: -
Atea Pharmaceuticals
Feb 15, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.49
Upside: -